The Use of Reynolds Risk Score in Cardiovascular Risk Assessment in Apparently Healthy Bosnian Men and Women: Cross-Sectional Study by Asija Začiragić
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
18 
The Use of Reynolds Risk Score in 
Cardiovascular Risk Assessment in Apparently 
Healthy Bosnian Men and Women: 
Cross-Sectional Study 
Asija Začiragić 
Department of Physiology, School of Medicine, University of Sarajevo, 
Bosnia and Herzegovina 
1. Introduction 
Cardiovascular diseases (CVD) remain a major burden for public health worldwide. Pivotal 
concern of primary prevention is identification of individuals that are at risk for developing 
cardiovascular disease. The use of different algorithms for an assessment of cardiovascular 
risk allows physicians to identify and treat in a simple and cost-effective manner individuals 
that may be at high long-term cardiovascular risk. 
A cardiovascular risk factor represents a condition that is related to increased risk for the 
development of cardiovascular disease. This relation is used in statistical terms. If certain 
individual has particular risk factor he/she has increased probability for the development of 
CVD. However, not all individual with cardiovascular risk will develop CVD and 
sometimes coronary events may occur in the absence of major risk factors (Ridker et al, 
JAMA 2007). Identification of individuals at cardiovascular risk results in a cost-effective 
prevention. Significant efforts are made to ensure most reliable tools in cardiovascular risk 
assessment. For a risk factor to be useful in routine clinical diagnostics, following criteria 
must be fulfilled: its analysis must be easy and available, there must be pathophysiological 
evidence that confirms causal link of risk factor with the disease, and also there must be 
certain knowledge on treatment options for patients with established high values of a 
certain risk factor (Thomas et al, 2009).  
Cardiovascular risk factors are divided into three main categories: non-modifiable (age, 
gender, heredity); modifiable (increased blood pressure, dyslipidemia, fibrinogen, obesity, 
glucose intolerance, diabetes, left ventricular hypertrophy, cocaine, behavioral factors); and 
protective factors (HDL-cholesterol, exercise, estrogen, moderate alcohol intake). It is 
important to emphasize that treatment of certain modifiable cardiovascular risk factor will 
not result in total elimination of probability in CVD development, but the possibility of CVD 
development will be reduced.  
As for non-modifiable cardiovascular risk factors, many epidemiological studies have 
reported age as one of the strongest predictors of CVD. Furthermore, investigations have 
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shown that men are more prone to CVD development then women for reason yet not 
completely understood. In most societies, development of cardiovascular risk factors begins 
in younger age, and manifests itself in middle age. Almost 85% of all deaths due to CVD 
occur in people 65 years of age or older. It has been reported that mortality rate for men 
before the age of 50 with no pre-existing myocardial infarction or stroke was 20%, which 
increased up to 80 % in those older then 70 years of age (Wannamethee et al, 1995).  
Inherited likelihood for the development of CVD has been well documented. In some cases, 
such as familial hypercholesterolemia ways of inheritance are well defined. However, for 
other cardiovascular risk factors pattern of inheritance is still unknown. According to 
current assumptions, role of heredity in the development of CVD is multifactorial with 
genetic, environmental, and behavioral component (Phillips et al, 1988). Studies have shown 
that risk of developing premature CVD was increased more then threefold when any first-
degree relative was affected and about sixfold when at least two first-degree relatives had a 
history of CVD (Eaton et al, 1996). 
Of all the modifiable cardiovascular risk factors, hypertension is best investigated. Both 
systolic and diastolic blood pressures are important in the assessment of individual’s risk. 
However, majority of complications of hypertension are attributed to systolic blood 
pressure. Studies have indicated that the risk of a cardiac event increases by 1.6 in men and 
2.5 in women when blood pressure rises from an optimal (<120/80 mmHg) to high normal 
(130-139/85-89 mmHg) level (Vasan et al, 2000). Although hypertension is an independent 
cardiovascular risk factor, data have shown its strong relations with other risk factors, such 
as age, sex, race and hypercholesterolemia.  
Increased levels of serum lipids are another common modifiable cardiovascular risk factor. 
According to current guidelines fasting lipoprotein profile (total cholesterol, triglycerides, 
LDL-cholesterol and HDL- cholesterol) should be preformed every five years in all adults 
age 20 years and older. Level of total cholesterol is strong predictor of CVD and to a lesser 
degree of stroke. Close linear relationship exists between cholesterol level and the mortality 
rate. Studies have shown that low-density cholesterol (LDL-C) and high-density cholesterol 
(HDL-C) and their relationship may have even more significant prognostic value in the 
prediction of CVD then total cholesterol. Men aged 45 to 65 years with total serum 
cholesterol level < 240 mg/dL and/or LDL-cholesterol > 160 mg/dL are considered to be at 
an increased risk for CVD (Wilson et al, 1998). Reduction of increased levels of total 
cholesterol and LDL-cholesterol is accompanied with the decline of cardiovascular risk. 
Earlier studies failed to demonstrate predictive value of triglycerides, but results of novel 
studies point to possible importance of triglycerides in the prediction of cardiovascular risk, 
especially in women and patients with diabetes. HDL-cholesterol attenuates atherogenicity 
of LDL-cholesterol. High levels of HDL-cholesterol have protective properties, while its low 
levels represent a major risk for CVD (P.W. Wilson, 1990; Schafer et al, 1994). 
Recent data report on possible role of fibrinogen as cardiovascular risk factors. Even though 
mechanisms by which fibrinogen fulfills this role are still not completely known, it is 
believed that individuals with raised fibrinogen are more susceptible to the development of 
clots in arteries, and thereby have increased risk of heart attack or stroke. Evidences have 
shown that fibrinogen levels have tendency to rise with advancing age and in that sense 
fibrinogen does not represent modifiable cardiovascular risk factor. However, it has been 
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proven that smoking cessation reduces fibrinogen levels which make fibrinogen a 
cardiovascular risk factor that can be controlled. In a 13-year longitudinal CARDIA study 
(D. Green et al, 2010) higher levels of fibrinogen during young adulthood were positively 
associated with incidence of subclinical atherosclerosis and coronary artery calcification in 
middle-age. However, study has shown that this association declines with advancing age.  
A major contributor to CVD is cigarette smoking. It is estimated that out of approximately 
500.000 deaths from coronary heart disease, 30-40% can be attributed to smoking. Studies 
have shown that risk of sudden death increases more then tenfold in men and almost 
fivefold in women who smoke. Smoking is associated with accelerated atherosclerosis and 
inflammatory processes. Smoking cessation and reduced tobacco exposure result in decrease 
of inflammatory component of CVD and this decrease is reversible (Bakhru & Erlinger, 2005; 
Tracy et al, 1997; Dobson et al, 1991).  
Obese individuals (more then 30% over ideal body weight) are more likely to develop CVD, 
even in absence of other cardiovascular risk factors. A strong association has been found 
between overweight that begins in childhood and the development of other risk factors over 
time, such as hypertension and diabetes. The cause of overweight and obesity in majority of 
cases is excessive food intake and sedentary lifestyle. A study among middle-aged men has 
shown that risk of developing fatal and non-fatal CVD increased up to 72% if their body 
mass index (BMI) increased from less then 23 to the range of 25-29 (Rimm et al, 1995). For all 
of these reasons obese individuals tend to be at high risk for CVD, and weight management 
is extremely important lifestyle intervention that can lead to significant reduction of 
cardiovascular risk.  
Individuals with glucose intolerance and diabetes mellitus have increased risk for CVD. 
These two conditions are often accompanied with raised levels of insulin that in this setting 
increases blood pressure and aids in plaque deposition. As a result of these insulin actions, 
atherosclerosis and its complications will develop. Data have reported that there is a liner 
association between glucose levels and CVD mortality (Balkaue et al, 1999). It is of note that 
influence of diabetes mellitus on the development of CVD differs among ethnic groups. A 
prospective study in individuals of African-American origin has shown that 27% of women 
and 8% of men had CVD that could be attributed to diabetes mellitus. In individuals of 
Caucasian origin, 15% of men and 12% of women had CVD that could also be attributed to 
diabetes mellitus (Folsom et al, 1997)  
Even though certain authors disagree, many others find behavioral risk factors such as type 
A personality and stress as important risk factors for CVD. Type A or coronary-prone 
personality is an individual that is always in hurry, under pressure by time, becomes upset 
often with no objective reason, has chronic impatience and sometimes overwhelming 
hostility. Results from GAZEL French prospective study have demonstrated that neurotic 
hostility, coronary-prone personality and antisocial personality are all predictive of 
mortality outcomes (Nabi et al, 2008).  
Left ventricular hypertrophy (LVHT) is a major independent risk factor for cardiovascular 
mortality. Studies have shown that individuals with LVHT are more susceptible to 
arrhythmias, heart failure and sudden death and this condition is often accompanied with 
hypertension. Appropriate treatment of these conditions reduces cardiovascular risk. Novel 
findings suggest that there are racial and ethnic differences in cardiovascular mortality related 
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to LVHT. It has been demonstrated that LVHT contributes more to the risk of cardiovascular 
mortality in African American then it does in White individuals (Havranek et al, 2008).  
Cocaine is a sympathomimetic agent that can cause hypertension, arrhythmias, angina and 
sudden death. Cocaine is also a risk for congenital heart disease. Main mechanism of cocaine 
action is that it constricts coronary blood vessels and reduces oxygen supply to the heart. It 
has been reported that concomitant use of cigarettes exacerbates the deleterious effects of 
cocaine on myocardial oxygen supply and demand (Lange et al, 2004).  
Alongside with non-modifiable and modifiable cardiovascular risk factors, there are also 
some proven protective factors that in fact protect from the development of CVD. Sedentary 
life-style is associated with the development of obesity, metabolic risk factors, insulin 
resistance, and early onset of diabetes mellitus type 2. Regular exercise is one of those 
protective factors that helps in weight management, increases HDL-cholesterol 
concentration, enhances utility of insulin in organism, reduces stress and decreases blood 
pressure. There are convincing data that it also reduces chances for having a myocardial 
infarction. Significant changes in classical cardiovascular risk factors are preceded by 
reductions of vascular functions. Important guidelines for primary and secondary 
prevention settings should be based on the encouragement of regular physical activity that 
has been shown to have many beneficial effects on the vascular wall (D.J. Green et al, 2008). 
Studies have found that increased physical activity leads to the decline of CVD mortality 
(Blair et al, 1995). Results of a meta-analysis reported that physical activity was inversely 
associated to the development of CVD, with a relative increased risk of 1.9 in people with 
sedentary lifestyle compared to physically active individuals (Berlin et al, 1990).  
Another protective factor against CVD is estrogen. It reduces likelihood of heart attack by 
increase in HDL-cholesterol levels. However, once women reach an age of menopause this 
protective action of estrogen diminishes, and women are at same cardiovascular risk as 
men. According to recent findings, estrogen decreases production of reactive oxygen species 
in mitochondria. Studies have shown that estrogen promotes angiogenesis, enhances 
endothelial vasodilator function and modulates autonomic function (Miller et al, 2008).  
Moderate alcohol consumption is proven to have protective effects against atherosclerosis 
and coronary heart disease. Mechanisms by which these effects are achieved are still not 
completely understood, but it seems that consumption of one or two drinks a day increases 
levels of HDL-cholesterol. A systematic review of literature and meta-analysis on 
association between alcohol consumption and overall mortality from CVD, incidence of and 
mortality from coronary heart disease, and incidence of and mortality from stroke has 
observed that light to moderate alcohol consumption is associated with reduced risk of 
multiple cardiovascular outcomes (Ronksley et al, 2011). However, consumption of alcohol 
in larger amounts increases blood pressure and risk of CVD.  
Prevalence of cardiovascular risk factors differs around the globe. Data from USA indicate 
that nearly 70% of adult Americans are overweight or obese. Less than 15% of adults or 
children exercise sufficiently, and over 60% do not engage in vigorous activity. Among adult 
population, 11%–13% have diabetes, 34% have hypertension, 36% have prehypertension, 
36% have prediabetes, and 12% have both prediabetes and prehypertension, At least one 
cardiovascular risk factor is present in 50% of adults. Furthermore, almost 65% of patients 
do not have their traditional cardiovascular risk biomarkers under control (Kones, 2011).  
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Another study in US population (Danaei et al, 2009) aimed to assess the number of disease-
specific deaths attributable to all non-optimal levels of risk factors exposure, by age and sex. 
Results have shown that in year 2005, cigarette smoking was responsible for an estimated 
467.000 deaths and high blood pressure for 395.000 deaths in US adults. Overweight-obesity, 
physical inactivity, and high blood glucose caused 8%-9% of all deaths in same population. 
Other dietary risk factors also caused significant number of deaths in the US.  
A comprehensive, population-based study compared cardiovascular risk profiles among 
individuals of white, South Asian, Chinese and black ethnic groups living in Canada (Chiu 
et al, 2010). Results have shown that there is a considerable variation in the prevalence of 
smoking, hypertension, obesity, and diabetes mellitus among four ethnic groups included in 
the study. Authors concluded that these results may lead to the development of CVD 
prevention programs for specific ethnic groups. 
Prediction of risk for future cardiovascular events or stratification of healthy individuals 
into risk categories by different algorithms has been widely used in clinical practice. 
Important issue is critical appraisal of implemented prediction models. Even though 
validity of models can be evaluated by different means, calibration and discrimination 
represent two most important measures of accurate models assessment. Calibration is a 
measure of how well predicted probabilities agree with actual observed risk, whereas 
calibration is a measure of how well the model can separate those who do and do not have 
the disease of interest. A measure of discrimination that is broadly used is c statistics, also 
known as the area under the Receiver Operating Characteristic (ROC) curve, or c index. 
Results of a Women Health Study have shown that use of c statistics can be advocated 
because of its specificity and sensitivity in differentiating between those who do and those 
who do not have a certain disease. Also, its use may contribute to more exact reclassification 
of large proportion of patients into higher- risk or lower-risk categories. However, it seems 
unlikely that it can be used in the evaluation of algorithms that predicts future risk or 
stratify individuals into risk categories. Another conclusion of this study was that use of c 
statistics as the only measure of the possible usefulness of traditional or novel risk factors 
could not be advised (Cook N, 2007). Finally, decision on inclusion of novel risk marker in 
prediction algorithms should be based on the knowledge whether measurement of potential 
risk marker will result in different treatment options, and whether it has perspectives in 
disease prevention.  
Etiology of CVD is multifactorial. In order to better assess cardiovascular risk, new 
biomarkers have been introduced as part of global cardiovascular risk assessment. Novel 
findings suggest that important role in atherosclerosis has inflammation. These conclusions 
led to the measurement of numerous markers of inflammatory processes to better identify 
individuals that are at the increased risk. C-reactive protein (CRP) is currently most studies 
and best validated biomarker of inflammatory processes. It is an acute phase protein, which 
is primarily synthesized in the liver and it represents a marker of systemic, non-specific, 
inflammation. CRP production is stimulated by cytokines (in particular interleukin-6, 
interleukin-1, and tumor necrosis factor-alpha) in response to systemic or local infection or 
inflammation by variety of cells, including adipocytes (Pepys & Hirschfield, 2003).  
The Centers for Disease Control and Prevention and the American Heart Association 
published a statement in 2003 in which measurement of CRP is given at the discretion of 
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physicians to be used in clinical practice as part of global risk assessment in adults (Pearson 
et al, 2003). According to existing guidelines, individuals with CRP values < 1 mg/L are 
considered to be in low, those with CRP values 1-3 mg/L in moderate and those with CRP 
values > 3 mg/L in high cardiovascular risk (Packard et al, 2008).  
Current main goal in CRP testing is to identify individuals that can benefit from lipid-
lowering treatment in order to prevent first cardiovascular event, especially for those 
individuals that have CRP > 3mg/L, and are in intermediate risk (10-20% 10-year predicted 
risk). However, it is of critical importance in any interpretation of CRP values to 
differentiate modest increase of CRP baseline values from its major rise that occurs in 
conditions such as tissue necrosis, sepsis and acute trauma. Furthermore, because of its 
completely unspecific nature, it is not possible or clinically appropriate to interpret CRP 
values without full medical information of individual, including history, physical 
examination, and results of all investigations (Casas et al, 2008). Although more 
sophisticated inflammatory biomarkers (such as interleukin-6, intercellular adhesion 
molecule-1, macrophage inhibitory cytokine-1, and CD40 ligand) have been shown to be 
predictive of cardiovascular disease, their use in routine clinical evaluation is highly 
unlikely because of short half-lives of these proteins (Katrinchak &Fritz, 2007 ). 
Findings of many clinical, experimental, prospective epidemiological and cohort studies have 
demonstrated that CRP may play role in atherogenesis, since it was found in endothelial 
atherosclerotic lesions, and raise in CRP concentrations is linked with the increased prevalence 
of myocardial infarction, peripheral vascular disease, and stroke. Furthermore, CRP provides 
additional information for the prevention of cardiovascular disease, has a prognostic value of 
incident cardiovascular events in those with and without preexisting CVD, the increased risk 
associated with high CRP is independent of other established risk factors, and CRP is 
biologically stable over time and assays for its measurements are standardized (de Ferranti et 
al, 2007). For all of the stated properties, certain authors believe that CRP represents not only a 
marker but as well a mediator of cardiovascular disease (Ridker et al, 2004). Conversely, there 
are studies that reported that CRP is only a relatively modest predictor of coronary heart 
disease, and suggest that its use in the prediction of coronary heart disease development 
should be revised (Danesh et al, 2004).  
Data have shown that conventional cardiovascular risk factors fail to predict development 
of coronary heart disease in 25-50% of cases. Certain authors believe that possible 
explanation of observed discrepancy may be endothelial dysfunction that may be a missing 
link between atherosclerotic disease and cardiac risk factors (Reriani et al, 2010). According 
to relatively recent hypothesis endothelial dysfunction has significant impact on the 
development and progression of atherosclerosis and atherothrombosis. One of the currently 
mostly used markers of endothelial dysfunction is asymmetric dimethylarginine (ADMA). 
ADMA is a endogenous inhibitor of all three isoforms of the enzyme nitric oxide synthase 
(NOS) and causes endothelial dysfunction by inhibiting production of nitric oxide (one of 
the major endothelium-derived vasoactive mediators). Prospective clinical studies have 
shown that elevated levels of ADMA are related to increased incidence of cardiovascular 
events, as well as with overall mortality (Anderssohn et al, 2010). Large multicentric 
CARDIAC study has found that elevated ADMA concentration significantly increases the 
risk of coronary heart disease (Landim et al, 2009). These findings point to the important 
role of functional vascular status in cardiovascular prognosis. However, it remains unclear 
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whether increased values of ADMA represent only a marker of endothelial dysfunction that 
may be used in cardiovascular risk assessment or elevated ADMA concentration itself 
predispose the development of CVD.  
Alongside with conventional biomarkers for the prediction of incident cardiovascular 
events, there are also some other novel biomarkers that are tested for their possible 
usefulness in cardiovascular risk assessment. Recent Swedish study assessed a panel of 
contemporary biomarkers, such as mid-regional-pro-atrial natriuretic peptide, N-terminal 
pro-B-type natriuretic peptide (N-BNP), mid-regional-pro-adrenomedullin (MRproADM), 
lipoprotein-associated phospholipase-2, and cystatin C in prediction of future 
cardiovascular events. Results have shown that 10-year incidence of coronary events was 
4.4%. Another important finding of the study was that selected biomarkers may be used in 
the prediction of future cardiovascular events, but benefits over traditional risk factors are 
minimal. Furthermore, their use did not reclassify a substantial proportion of individuals to 
higher or lower risk categories (Melander et al, 2009). 
A study in Hispanic population used standard risk assessment tools and the B-type 
natriuretic peptide biomarker to assess coronary heart disease risk (Macabasco-O’Connell et 
al, 2011). Based on their findings, authors concluded that the inclusion of B-type natriuretic 
peptide to the traditional risk scores may be helpful in cardiovascular risk prediction. 
One of the most frequently used cardiac risk prediction model in clinical practice is 
Framingham Risk Score. Its use started in the 1980s and based on its implementation in 
cardiovascular risk assessment, individuals can be divided in those at low (less then 5%), 
intermediated (6-20%) and high (>20%) cardiovascular risk (Ridker et al, 2004). However, 
over time, Framingham Risk Score showed certain limitations. Evidences have shown that 
cardiovascular events occur in every fifth individual in whom classical risk factors have not 
been recognized. Furthermore, there is a limitation in specificity of conventional risk factors 
and it has been shown that overall cardiovascular risk differs across populations. It has also 
been concluded that intermediate risk category is broad and that there is a necessity for 
better risk stratification of that risk category. For all of the above reasons, there was a need 
for new and more comprehensive cardiovascular risk prediction tools. 
So far, several other risk prediction models have been proposed to be used in every-day 
clinical practice for cardiovascular risk assessment, such as: Adult Treatment Panel III, 
ASSIGN (Assessing Cardiovascular Risk to Scottish Intercollegiate Guidelines Network), 
QRISK (QRESEARCH Cardiovascular Risk Algorithm), and SCORE (Systematic Coronary 
Risk Evaluation) project (Berger et al, 2010). 
Majority of the studies so far evaluated risk of CVD in a 10-year or shorter time period. 
Contrary to these studies, there is a study in which individuals, free of conditions at 
baseline, were followed-up for 30-years and in that period incidence of CVD and death was 
ascertained. Results of this study demonstrated that standard risk factors remain highly 
predictive of cardiovascular risk over 30-years follow-up period and their impact is 
significant even if levels are not updated (Pencina et al, 2009).  
A global vascular risk score was recently designed and validated that combines 
conventional risk factors with behavioral (alcohol consumption and physical activity) and 
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anthropometric risk factors in African-American and Hispanic individuals at risk for 
vascular disease (Sacco et al, 2009). The use of this risk prediction model demonstrated an 
improvement in the prediction of global vascular risk.  
Reynolds Risk Score (RRS) represents risk prediction algorithm that was designed, validated 
and used in the prediction of 10-year cardiovascular risk in initially healthy men and 
women. It is based on two separate large prospective studies that included more then 20.000 
women, 45 years of age and older, with median follow-up period of 10.2 years and more the 
10.000 men, 50 years of age and older, that were followed up over a median period of 10.8 
years for incident myocardial infarction, stroke, coronary revascularization, or 
cardiovascular death (Ridker 2007, 2008). The main aim of these two studies was to compare 
predictive value of traditional risk prediction model based on age, blood pressure, smoking 
status, total cholesterol and high-density lipoprotein cholesterol and RRS in which alongside 
with traditional risk markers, hsCRP and parental history of cardiovascular diseases are 
included. Results have confirmed significant predictive value of traditional risk factors as 
well as of hsCRP and parental history. Furthermore, both of the studies have shown that 
RRS had better predictive value in the prediction of incident cardiovascular events in 
women and in men compared to traditional cardiovascular risk prediction model. Study in 
initially healthy female subjects have also demonstrated that use of RRS improved risk 
stratification in a sense that 40-50% of women that were previously categorized to be at 
intermediate risk could be reclassified into higher or lower risk categories. Study in initially 
healthy male subjects showed that up to 20% of men previously categorized to be at 
intermediate risk could be reclassified into higher or lower risk categories. Conclusion 
derived from both of the studies was that use of RRS can serve in primary prevention 
settings to better targeting of treatments in order to increase benefits and reduce toxicity. 
RRS comprises of four 10-year risk categories: 0% to less then 5% - low risk category, 5% to 
less then 10% - low to medium risk category, 10% to less then 20% - medium to high risk 
category, and > 20% – high risk category (Ridker et al, 2004; Cook et al, 2006).  
To date, no data exist on use of RRS in cardiovascular risk assessment among apparently 
healthy Bosnian men and women. To address this issue, we used Reynolds Risk Score 
calculator (http://www.reynoldsriskscore.org) to ascertain 10-year cardiovascular risk with 
the use of traditional factors such as age, smoking status, systolic blood pressure, blood 
levels of total cholesterol, HDL-cholesterol, as well as hcCRP and parental history of 
myocardial infarction and stroke before the age 60 in our study sample.  
2. Methods 
2.1 Subjects 
Between February and March 2011, 230 of men and 270 women visited Family Medicine Out-
Patient Clinic “Visnjik”, Sarajevo, Bosnia and Herzegovina, for general health screening. 
Among them, 200 of men and 250 women signed informed consent. Excluding subjects with 
history of cardiovascular disease, malignancy, liver disease, alcohol abuse, use of antidiabetic, 
antihypertensive, or lipid-lowering drugs, or CRP values > 10 mg/L, and those aged < 45 
years, the resulting 76 men and 120 women comprised the subjects in the present study. The 
study was approved by the Ethics Committee of the Medical Faculty University of Sarajevo. 
Written informed consent was obtained from all subjects included in the study. Participants 
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underwent a medical history, physical examination and laboratory assessment. Investigations 
were carried out in accordance with the Declaration of Helsinki as revised in 2000.  
2.2 Blood sampling 
Blood was collected in the morning after an overnight fast and after a 30-minutes rest in a 
semi-recumbent position. Sampling was done without stasis, using the vacutainer technique.  
2.3 Blood chemistry analysis 
High sensitivity CRP was determined by means of particle enhanced immunonephelometry 
(BN Systems, Dade Behring, Marburg, Germany). The lower limit of detection of this assay 
was 0.18 mg/L. Levels of hs-CRP >10mg/L were excluded from the analysis, as they are 
likely related to infections or other acute inflammatory processes. Total cholesterol, HDL - 
cholesterol, triglycerides were measured by direct colorimetric reflectance 
spectrophotometry using Dimension clinical chemistry system (Dade Behring, Marburg, 
Germany). LDL - cholesterol was calculated by means of Friedwald formula.  
2.4 Blood pressure measurements 
Three supine blood pressure recordings were made after a 5-minutes rest using an Omron 
705c oscillometric device. The mean of the second and third readings was used. 
Hypertension was defined as systolic blood pressure ≥140 mmHg, diastolic pressure ≥90 
mmHg, or self-reported high blood pressure with use of anti-hypertensive medications. 
Prehypertension was defined as systolic blood pressure of 120–140 mmHg or diastolic blood 
pressure of 80–90 mmHg. 
None of the included subjects was pregnant or had a history of intercurrent diseases. 
Parental history of myocardial infarction or stroke before the age 60 (genetic factor) was 
defined as family history of heart disease or stroke. Smoking status and genetic factor were 
assessed by self-administrated questioner. 
Statistical analysis. The Kolmogorov-Smirnov test of normality was used to test the 
distribution of variables. Normally distributed data are presented as mean ± SEM and 
skewed variables as median and interquartile ranges. An unpaired Student t-test or Mann-
Whitney U-test was used to compare the difference between two groups, as appropriate. 
Frequencies were tested by Chi-square test. In order to determine the factors associated with 
absolute 10-year Reynolds Risk Score, multiple regression analysis was performed. A p 
value of less then 0.05 was considered statistically significant. The software used was SPSS 
for Windows (version 17.0; SPSS, Chicago, IL, USA). 
3. Results 
Variables Men 
(n=76) 
Women 
(n=120) 
p< 
Age (yrs) 58.64±2.12 57.06±1.67 NS 
Smoking (yes/no) (29/47) (36/84) NS 
SBP (mmHg) 136.43±2.13 130.92±1.71 0.05 
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Variables Men 
(n=76) 
Women 
(n=120) 
p< 
TC (mmol/L) 5.48±0.13 6.01±0.12 0.001 
HDL (mmol/L) 1.22±0.04 1.39±0.03 0.001 
hsCRP (mg/L) 1.33(0.78-3.92) 1.71(0.80-3.92) NS 
GF (yes/no) (17/59) (11/109) 0.05 
Absolute RRS (%) 19.37±1.67 9.76±1.03 0.0001 
Data are presented as mean ± SEM, median and inter-quartile range, or in total count. SBP: systolic 
blood pressure; TC: total cholesterol; HDL-cholesterol: high density lipoprotein – cholesterol; hsCRP: 
high sensitivity C-reactive protein; GF: genetic factor; Absolute RRS: absolute Reynolds Risk Score, n: 
number of subject. 
Table 1. The values of Reynolds Risk Score factors in apparently healthy male and female 
subjects. Subjects did not differ in age, smoking status and CRP values. Statistically 
significant difference was observed in systolic blood pressure, total cholesterol, HDL-
cholesterol, genetic factor presence and in absolute Reynolds risk score values between men 
and women.  
 
Fig. 1. Frequency of Reynolds Risk Score categories by gender. Results have shown that 
6.63% of men and 28.6% of women were in low risk category, 5.6% of men and 11.2% of 
women in low to medium risk category, 9.7% of men and 12.2% of women in medium to 
high risk category, and 16.8% of men and 9.7% of women in high risk category.  
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Independent Variables ß coefficient t value p< 
Age (yrs) 0.553 7.753 0.0001 
Smoking (yes/no) 0.023 0.359 NS 
SBP (mmHg) 0.420 5.905 0.0001 
TC (mmol/L) 0.095 1.422 NS 
HDL (mmol/L) -0.016 -0.244 NS 
hsCRP (mg/L) -0.005 -0.073 NS 
GF (yes/no) -0.143 -2.244 0.05 
Table 2. Results of multiple regression analysis for absolute 10-year Reynolds Risk Score as 
dependent variable in men. Multiple regression analysis revealed that in male subjects most 
predictive value in cardiovascular risk assessment had age followed by systolic blood 
pressure and genetic factor, respectively. 
 
Independent Variables ß coefficient t value p< 
Age (yrs) 0.287 4.394 0.0001 
Smoking (yes/no) -0.230 -4.265 0.0001 
SBP (mmHg) 0.561 8.647 0.0001 
TC (mmol/L) 0.093 1.701 0.092 
HDL (mmol/L) 0.012 0.222 0.825 
hsCRP (mg/L) 0.075 1.367 0.174 
GF (yes/no) -0.044 -0.804 0.423 
Table 3. Results of multiple regression analysis for absolute 10-year Reynolds Risk Score as 
dependent variable in women. In female subjects most predictive value in cardiovascular 
risk assessment had systolic blood pressure, followed by age and smoking, respectively. 
4. Discussion 
CVD is one of the leading causes of death worldwide. It is estimated that for individuals at 
age of 50 years, the lifetime risk of CVD is, on average, for men 52% and 39% for women 
(Berger et al, 2010).  
To the best of our knowledge, we are the first to report high prevalence of cardiovascular 
risk factors in apparently healthy Bosnian men and women with the use of Reynolds Risk 
Score calculator. Results have shown that in a total study sample, 34.7% of subjects were in 
low, 16.8% in low to medium, 21.9% in medium to high, and 26.5% of subjects were in high 
cardiovascular risk category. Our results are consistent with previous report (Cushman et al, 
2009). Majority of women in both studies belonged to low and low to medium risk category 
group, and majority of men belonged to medium to high and high risk category group. The 
mean absolute 10-year cardiovascular risk determined with RRS calculator in men included 
in our study was 19.37%, and 9.97% in women. Our observations are not in accordance with 
the study among commercial pilots in UK that revealed that 9.7% of all male pilots were at 
high cardiovascular risk and that the mean 10-year cardiovascular risk for the entire pilot 
population was 8.41% (Houston et al, 2010).  
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Data on prevalence of cardiovascular risk factors in less developed countries are not 
abundant. In urban Tanzania, prevalence of cardiovascular risk factors was high, especially 
in women. The age-adjusted prevalence of obesity in men was 13%, and 35% in women. In 
men, BMI and waist circumference (WC) were significantly correlated with blood pressure, 
triglycerides, total cholesterol, LDL- cholesterol, and HDL-cholesterol (BMI only), and 
fasting glucose. Conversely, in women only blood pressure was positively associated with 
BMI and WC (Njelekela et al, 2009).  
Study in urban Asian Indian subjects observed low prevalence of smoking, hypertension, 
dyslipidemia, metabolic syndrome and diabetes in adolescents, with rapid escalation of 
these risk factors by age of 30-39 years (Gupta et al, 2009). 
Results of a first nationwide survey on cardiovascular risk factors in Grand-Duchy of 
Luxembourg have shown the most predominant cardiovascular risk factors was 
dyslipidemia (69.9%), followed with hypertension (34.5%), smoking (22.3%), and obesity 
(20.9%), while diabetes was present in 4.4% of study population. Furthermore, only 14.7% of 
men and 23.1% of women were free of any cardiovascular risk factor (Alkerwi et al, 2010). 
Studies have demonstrated that incidence and prevalence of CVD increase with advancing 
age. However, the predictive value of classic risk factors diminishes with age. The mean 
value of age of male participants in our study was 58.64 years, and of female participants 
57.06 years. There was no significant difference in age between these two groups. 
Population based observational cohort study in very old people (aged 85 years) with no 
history of CVD aimed to assess classic risk factors and some new biomarkers (homocysteine, 
folic acid, CRP, interleukin– 6) as predictors of cardiovascular mortality in this age group. 
Their results have shown that homocysteine alone accurately identified individuals at high 
cardiovascular risk, whereas classic risk factors included in the Framingham risk score did 
not (de Ruijter et al, 2008).  
A study that investigated age relations of blood pressure, anthropometric indexes, serum 
lipids, and hemostatic variables in a population of Papua New Guinea (Lindberg et al., 1997) 
has found that diastolic blood pressure was not associated with age, while systolic blood 
pressure linearly increased after 50 years of age in both sexes. BMI decreased with age in both 
sexes. Serum total cholesterol, triglycerides, LDL-cholesterol increased in males between 20 
and 50 years of age, whereas HDL-cholesterol decreased. Authors concluded that some of the 
relations of age with other cardiovascular risk factors represent effects of biological aging. 
Results from EURIKA study (Guallar et al, 2011), which involved participants from 12 
European countries with at least one cardiovascular risk, but without CVD reported that the 
average 10-year risk of CVD death in study participants was 8.2%. Hypertension was 
responsible for 32.7%, hyperlipidemia for 15.1%, smoking for 10.4%, and diabetes for 16.4% 
of CVD risk. The four risk factors accounted for 57.7% of CVD risk, representing a 10-year 
excess risk of CVD death of 5.66%. Study also demonstrated that lack of control of these 
cardiovascular risk factors was responsible for almost 30% of the risk of CVD death. 
Besides age, hypertension, smoking, diabetes, and hyperlipidemia, risk factors for CVD also 
include obesity, physical inactivity and insulin resistance. A study conducted among adults 
seeking primary care in Germany reported high prevalence of overweight and obese 
individuals. Furthermore, a high waist to hip ratio (WHR) was associated with an increased 
prevalence of high triglycerides, a high blood pressure, an increased fasting glucose, and the 
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presence of diabetes mellitus. On the other hand, a family history of myocardial infarction 
was not more frequent in patients with high WC compared to patients with normal WC. The 
prevalence of smoking was significantly lower in overweight men with an elevated and 
high WC, but not in women (Hauner et al, 2008).  
According to Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure, systolic blood pressures of 120–139 
mmHg and/or diastolic blood pressures of 80–89 mmHg are classified as prehypertension. 
Individuals with this condition are thought to be at increased risk of CVD. Results from a 
cross-sectional study in Jamaica have shown that the prevalence of prehypertension among 
Jamaicans was 30%. Prehypertension was found in 35% of male subjects, and 25 % of female 
subjects. Almost 46% of study participants were overweight; 19.7% were obese; 14.6% had 
hypercholesterolemia; 7.2% had diabetes mellituss, and 17.8% smoked cigarettes. With the 
exception of cigarette smoking and low physical activity, all the CVD risk factors had 
significantly higher prevalence in the prehypertensive and hypertensive groups compared 
to the normotensive group (Ferguson et al, 2008). Results of our study have shown that 
mean value of systolic blood pressure both in men and in women was bellow 140 mm/Hg. 
Men had significantly higher values of systolic blood pressure compared to women. 
Another observation of our study was that there was no significant difference in smoking 
status between men and women.  
Diets high in fat, especially saturated fat, are frequently associated with 
hypercholesterolemia, hypertension and obesity. Resent findings have reported significant 
increase in the prevalence of obesity in all age groups, including children, adolescents and 
adults. A study conducted among physically active college students reported that 45% of 
participants were overweight or obese. Furthermore, positive association between grain 
consumption, alcohol intake and BMI was observed. Another finding of this study was that 
high percentage of subjects had high WHR, elevated systolic and diastolic blood pressure, 
blood glucose and total cholesterol levels (Sharma et al, 2008). The average value of total 
cholesterol level both in men and women in our study was above referent limits. On the 
contrary, average values of HDL-cholesterol in both groups were within normal range. 
However, since we did not conduct a survey on dietary habits of our participants, we are in 
no position to draw any conclusions whether there is an association between total 
cholesterol and HDL-cholesterol values and dietary habits of our study sample. Future 
studies should address this issue, among population of Bosnia and Herzegovina, since it has 
been well documented that caloric intake differs between ethnicities, age and socioeconomic 
groups.  
The growing evidence supports the hypothesis that there is ethnic variation in CRP levels. 
Results of a large population-based study in Black and White men and women in the United 
States have shown that increased CRP values were more common among women than men, 
blacks than whites, and in the stroke belt compared to the rest of the U.S. Results of a same 
study also demonstrated that the use of RRS reclassified population to a different 10-year 
vascular risk level than the new Framingham Vascular Score (Cushman et al, 2009)). Our 
results did not show significant difference in CRP values between men and women included 
in our study. Thus, we were not able to confirm previous findings that gender influences 
CRP levels. However, this could be due to a limited size of our study sample.  
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Earlier results have demonstrated that inclusion of CRP in global risk prediction model 
improves risk classification in women (Cook et al, 2006). On the contrary, critical appraisal 
of literature on CRP measurement for the prediction of coronary heart disease event (Shah et 
al, 2009) have revealed that benefits of addition of CRP to models based on traditional risk 
factors are small and are only slightly resulting in better improvement in risk classification 
and reclassification. 
It is of interest to note that in the present study CRP did not show significant predictive 
value in cardiovascular risk assessment both in men and in women. Thus, data on possible 
use of CRP in cardiovascular risk assessment remain conflicting and inconsistent. Possible 
explanation for the observed inconsistency may be a fact that normal functions of CRP as 
well as its possible roles in diseases are yet incompletely defined (Casas et al, 2008). The 
reason for this is that so far no deficiency or structural polymorphism of human CRP have 
been reported nor is any therapeutic intervention available which specifically inhibits CRP 
in vivo. Consequently, until today the effects of absence, lack of function or inhibition of 
human CRP have not been tested. 
A large prospective study in Chinese male adults has demonstrated that hypertension and 
cigarette smoking were the leading predictive parameter for CVD (Ji et al, 2011). Our study 
had similar observations. We established that in male subjects most predictive value in 
cardiovascular risk assessment had age followed by systolic blood pressure and genetic 
factor, respectively. In female subjects, most predictive value in cardiovascular risk 
assessment had systolic blood pressure followed by age and smoking, respectively.  
Limitations of our study merit careful considerations. Importantly, present study was cross-
sectional and we did not include prediction of cardiovascular events. Subjects were not a 
general population but visitors to a Family Medicine Out-patient Clinic in capital city of an 
urban region in Bosnia and Herzegovina. Longitudinal studies and in larger populations are 
warranted to test present findings. Another limitation is that this study relied on self- reported 
smoking history and parental history of myocardial infarction which could bias the validity of 
findings. However, this potential limitation is extremely unlikely, because self-reported risk 
factors are commonly used in studies with reasonable accuracy (Sesso et al, 2001).  
5. Conclusion 
In conclusion, results of this cross-sectional study showed that significant proportion of our 
study sample belong to medium to high and high cardiovascular risk category. Significant 
reduction in cardiovascular risk can be achieved by scheduled cardiovascular risk 
assessment accompanied with appropriate interventions. One of the purposes of the present 
study was to inform physicians, especially in Bosnia and Herzegovina, about advantages of 
possible use of web-based RRS calculator in cardiovascular risk assessment of patients they 
treat in their everyday practice.  
The advantage of RRS is that it includes traditional cardiovascular risks accompanied with 
blood-based biomarkers and parental history of cardiovascular disease that results in better 
risk assessment and is easily accessible and cost-effective in primary prevention. With the 
use of RRS, we were able to identify individuals who may require more comprehensive risk 
stratification. Moreover, findings of the present study suggest that use of RRS may serve in 
better targeting of treatments in primary prevention settings.  
www.intechopen.com
The Use of Reynolds Risk Score in Cardiovascular Risk Assessment 
in Apparently Healthy Bosnian Men and Women: Cross-Sectional Study 
 
355 
RRS calculator provides information not only on total cardiovascular risk but also how 
control of certain cardiovascular risk can lead to the reduction of absolute cardiovascular 
risk in percentages. The use of RRS in cardiovascular risk assessment may result in a better 
compliance of patients and physicians in their joint efforts to achieve better control of 
cardiovascular risks. 
Based on the results of present study, physicians are strongly encouraged to promote and to 
intensify well established interventions such as blood pressure control, lipid reduction, 
smoking cessation, heart-healthy diet, physical activity and weight reduction. One can not 
foreseen that CVD will be eliminated in a near future, but education, screening, monitoring, 
and appropriate treatment will certainly lead to the decrease of the morbidity and mortality 
of these diseases.  
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